Month: <span>February 2019</span>

Home / 2019 / February
Post

Triazavirin defeats tick-borne encephalitis

The drug triazavirin, developed by the researchers of the Ural Branch of the Russian Academy of Sciences and the Institute of Chemical Engineering of Ural Federal University, has proved to be an effective remedy against tick-borne viral encephalitis (TBE). Clinical trials conducted by Krasnoyarsk State Medical University led to this conclusion. The results are published...

Post

What is RNA?

DNA vs. RNA Deoxyribonucleic acid (DNA) is a complex molecule that is primarily found within the nucleus of cells. DNA is present within all living organisms and contains the genetic instructions required for the development and maintenance of life. The structure of DNA versus RNA. ShadeDesign | Shutterstock The nucleic acid of DNA is deoxyribose,...

Post

How to talk to anti-vaxxers

When Rachel Alter started off as a graduate student, she expected to investigate epidemics, bioterrorism and disease eradication. But her focus started to shift after she began chatting with anti-vaxxers—people opposed to vaccination—on Facebook. Now, as a research assistant at the National Center for Disaster Preparedness at Columbia’s Earth Institute, she wants to find ways...

Post

Selfies to self-diagnosis: Algorithm ‘amps up’ smartphones to diagnose disease

Accessible, connected, and computationally powerful, smartphones aren’t just for “selfies” anymore. They have emerged as powerful evaluation tools capable of diagnosing medical conditions in point-of-care settings. Smartphones also are a viable solution for health care in the developing world because they allow untrained users to collect and transmit data to medical professionals. IMAGE: IMAGES OF...

Post

New diagnostic technique reveals a protein biomarker that accurately differentiates bladder cancer from benign inflammation

Philadelphia, PA, February 12, 2019 – Label-free digital pathology using infrared (IR) imaging with subsequent proteomic analysis for bladder cancer (BC) has revealed the first protein biomarker (AHNAK2) for BC. AHNAK2 differentiates between chronic cystitis (inflammation of the bladder) and a non-muscle invasive-type BC (carcinoma in situ) which is challenging to diagnose. A report in...

Post

GPs and pharmacists don’t have time to involve patients in medication reviews

GPs and pharmacists struggle to find the time to involve patients in medication reviews, despite National Institute for Health and Care Excellence (NICE) guidance advising them to do so, according to a study by researchers at the University of Bristol’s Centre for Academic Primary Care. Credit: CC0 Public Domain Medication reviews are important for patients...

Post

Top Smart Algorithms In Healthcare

As artificial intelligence tools have been invading more or less every area of healthcare, we made a list to keep track of the top A.I. algorithms aiming for better diagnostics, more sophisticated patient care or further sighted predictions of diseases. The Medical Futurist Does A.I. beat doctors? Only if you have lived under a rock...

Post

Depression drug related to ketamine wins endorsement of key advisory panel

An experimental medication for depression related to the hallucinogenic street drug ketamine won a crucial endorsement from an independent advisory committee convened by the Food and Drug Administration on Tuesday.   In a 14-to-2 vote, the panel said the benefits of the Johnson & Johnson drug, known as esketamine, outweigh the risks. The vote brings...

Post

New machine learning method could spare some women from unnecessary breast surgery

Saeed Hassanpour, PhD, found a machine learning method to predict the likelihood that a high-risk ADH breast lesion is cancerous. The approach can identify 98% of all malignant cases prior to surgery while sparing 16% of women from undergoing an unnecessary operation for a benign lesion. Once confirmed in larger studies, such models can be...